Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

Summary

RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have advanced or recurrent lymphoma.

Timeline

Start

2001-04

Primary completion

—

Completion

2003-10

Drugs

Indications